Newron Pharmaceuticals S.p.A. (SWX:NWRN)
Switzerland · Delayed Price · Currency is CHF 12.54
-0.04 (-0.32%)
Aug 21, 2026, 5:31 PM CET
Newron Pharmaceuticals Market Cap
Newron Pharmaceuticals has a market cap or net worth of 260.9 million as of August 21, 2026. Its market cap has increased by 69.75% in one year.
Market Cap
260.90M
Enterprise Value
269.55M
Revenue
17.81M
Ranking
n/a
PE Ratio
n/a
Stock Price
12.54
ChartMarket Cap Chart
Since December 12, 2006, Newron Pharmaceuticals's market cap has decreased from 309.05M to 260.90M, a decrease of -15.58%. That is a compound annual growth rate of -0.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 260.90M | -45.20% |
| Dec 30, 2025 | 476.07M | 173.36% |
| Dec 30, 2024 | 174.16M | 97.16% |
| Dec 29, 2023 | 88.33M | 219.35% |
| Dec 30, 2022 | 27.66M | -4.32% |
| Dec 30, 2021 | 28.91M | -24.65% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bachem Holding AG | 5.80B |
| Idorsia | 1.46B |
| Basilea Pharmaceutica AG | 801.24M |
| Santhera Pharmaceuticals Holding AG | 253.75M |
| BioVersys AG | 145.46M |
| Molecular Partners AG | 130.91M |
| Xlife Sciences AG | 86.67M |
| MindMaze Therapeutics Holding | 28.99M |